On Thursday, U.S. President Donald Trump unveiled a deal with Eli Lilly and Novo Nordisk, two American multinational pharmaceutical companies, to lower the prices of GLP-1 weight-loss drugs, making them more affordable for all consumers. This deal not only offers price cuts to drug treatments but also expands medical coverage.  Patients covered by Medicare, a […]